Asano Koichiro

Փ��

Real-world efficacy of anti-IL-5 treatment in patients with allergic bronchopulmonary aspergillosis.

Sensitization pattern to environmental allergens in a Japanese population

Treatments of refractory eosinophilic lung diseases with biologics.

Combination of computed tomography imaging pattern and severity of respiratory failure as factors associated with prognosis for acute exacerbation of idiopathic chronic fibrosing interstitial pneumonia.

Can MASCC and CISNE scores predict delays of lung cancer chemotherapy after febrile neutropenia?

Moldy odor from air conditioners in the residences of Japanese participants with and without asthma

Bacterial Communities in Various Parts of Air-Conditioning Units in 17 Japanese Houses

Prognosis of acute exacerbation in idiopathic pulmonary fibrosis with pulmonary emphysema: a retrospective cohort study in Japan.

Prevalence of inhaled allergen-specific IgE antibody positivity in the healthy Japanese population.

Diagnosis of pleural empyema/parapneumonic effusion by next-generation sequencing.

New clinical diagnostic criteria for allergic bronchopulmonary aspergillosis/mycosis and its validation.

Optimal Aspergillus fumigatus and Asp f 1 serum IgG cut-offs for the diagnosis of allergic bronchopulmonary aspergillosis.

Repeated exacerbation by environmental exposure and spontaneous resolution of allergic bronchopulmonary mycosis.

Clinical characteristics of patients with not well-controlled severe asthma in Japan: Analysis of the Keio Severe Asthma Research Program in Japanese population (KEIO-SARP) registry.

Adult-onset eosinophilic airway diseases.

Etiology and prognosis of spontaneous pneumothorax in the elderly.

Rapid clearance of mepolizumab-resistant bronchial mucus plugs in allergic bronchopulmonary aspergillosis with benralizumab treatment.

Evaluating serum periostin levels in allergic bronchopulmonary aspergillosis.

Deficiency of CRTH2, a Prostaglandin D2 Receptor, Aggravates Bleomycin-induced Pulmonary Inflammation and Fibrosis.

Allergic bronchopulmonary mycosis - pathophysiology, histology, diagnosis, and treatment.

Eosinophils release extracellular DNA traps in response to Aspergillus fumigatus.

Allergic bronchopulmonary aspergillosis in Japan: A nationwide survey.

Subphenotypes of type 2 severe asthma in adults

Allergic Bronchopulmonary Aspergillosis-A Luminal Hypereosinophilic Disease With Extracellular Trap Cell Death.

Characteristics of severe asthma with fungal sensitization.

A portable system for rapid bacterial composition analysis using a nanopore-based sequencer and laptop computer.

Post-bronchoscopy pneumonia in patients suffering from lung cancer: Development and validation of a risk prediction score.

Clinical contributions of exhaled volatile organic compounds in the diagnosis of lung cancer.

BMPR2 mutations and survival in pulmonary arterial hypertension: an individual participant data meta-analysis.

Interferon and IL-27 antagonize the function of group 2 innate lymphoid cells and type 2 innate immune responses.

Molecular-based allergy diagnosis of allergic bronchopulmonary aspergillosis in Aspergillus fumigatus-sensitized Japanese patients

Group 2 innate lymphoid cells and asthma.

Phenotype of asthma related with high serum periostin levels.

Dysregulated synthesis of protectin D1 in eosinophils from patients with severe asthma.

Thymic stromal lymphopoietin induces corticosteroid resistance in natural helper cells during airway inflammation.

CRTH2 is a critical regulator of neutrophil migration and resistance to polymicrobial sepsis.

Resolvin E1 maintains macrophage function under cigarette smoke-induced oxidative stress.

Induction of mucin and MUC5AC expression by the protease activity of Aspergillus fumigatus in airway epithelial cells.

Role of prostaglandin D(2) and its receptors in the pathophysiology of asthma.

��ͬ�о�?�������Y��Ȥ��о��n�}

Mycobiota in the airways of allergic bronchopulmonary mycosis

Metabolomics-based molecular phenotyping of severe asthma

The efficacy and role ofanti-lipid mediators on pulmonary fibrosis

Immunomodulatory role of PGD2/CRTH2 pathway in the pathophysiology of refractory lung diseases

Prostaglandin D2 and its receptors in the pathogenesis of refractory inflammatory pulmonary diseases

Serum cystatin C as a new marker for determining the optimal dosage of renally excreted drugs.

Relationship between CC chemokine expression in the airways of severe asthmatics and steroid resistance

Genetic factors that determine the responsiveness to platelet activating factor and their association with asthma